110 related articles for article (PubMed ID: 32413362)
21. RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2.
Zou Q; Wu H; Fu F; Yi W; Pei L; Zhou M
Arch Biochem Biophys; 2016 Nov; 610():25-32. PubMed ID: 27651238
[TBL] [Abstract][Full Text] [Related]
22. Nuclear Localization Signal-Enhanced Polyurethane-Short Branch Polyethylenimine-Mediated Delivery of Let-7a Inhibited Cancer Stem-Like Properties by Targeting the 3'-UTR of HMGA2 in Anaplastic Astrocytoma.
Yang MY; Chen MT; Huang PI; Wang CY; Chang YC; Yang YP; Lo WL; Sung WH; Liao YW; Lee YY; Chang YL; Tseng LM; Chen YW; Ma HI
Cell Transplant; 2015; 24(8):1431-50. PubMed ID: 24898358
[TBL] [Abstract][Full Text] [Related]
23. Circ_0000267 promotes gastric cancer progression via sponging MiR-503-5p and regulating HMGA2 expression.
Cai X; Nie J; Chen L; Yu F
Mol Genet Genomic Med; 2020 Feb; 8(2):e1093. PubMed ID: 31845519
[TBL] [Abstract][Full Text] [Related]
24. Dicoumarol suppresses HMGA2-mediated oncogenic capacities and inhibits cell proliferation by inducing apoptosis in colon cancer.
Chen CH; Hsieh YC; Yang PM; Liu YR; Cho EC
Biochem Biophys Res Commun; 2020 Apr; 524(4):1003-1009. PubMed ID: 32063361
[TBL] [Abstract][Full Text] [Related]
25. miRNA-101 Suppresses Epithelial-to-Mesenchymal Transition by Targeting HMGA2 in Pancreatic Cancer Cells.
Jiang W; Gu W; Qiu R; He S; Shen C; Wu Y; Zhang J; Zhou J; Guo Y; Wan D; Li Z; Deng J; Zeng L; Tang J; Zhou J; Zhi Q; Deng X
Anticancer Agents Med Chem; 2016; 16(4):432-9. PubMed ID: 25968875
[TBL] [Abstract][Full Text] [Related]
26. Let-7a inhibits migration, invasion and epithelial-mesenchymal transition by targeting HMGA2 in nasopharyngeal carcinoma.
Wu A; Wu K; Li J; Mo Y; Lin Y; Wang Y; Shen X; Li S; Li L; Yang Z
J Transl Med; 2015 Mar; 13():105. PubMed ID: 25884389
[TBL] [Abstract][Full Text] [Related]
27. HMGA2 promotes vasculogenic mimicry and tumor aggressiveness by upregulating Twist1 in gastric carcinoma.
Sun J; Sun B; Sun R; Zhu D; Zhao X; Zhang Y; Dong X; Che N; Li J; Liu F; Zhao N; Wang Y; Zhang D
Sci Rep; 2017 May; 7(1):2229. PubMed ID: 28533522
[TBL] [Abstract][Full Text] [Related]
28. High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia.
Unachukwu U; Chada K; D'Armiento J
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365712
[TBL] [Abstract][Full Text] [Related]
29. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition.
Lee J; Ha S; Jung CK; Lee HH
Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850
[TBL] [Abstract][Full Text] [Related]
30. Elevated HMGA2 expression is associated with cancer aggressiveness and predicts poor outcome in breast cancer.
Wu J; Zhang S; Shan J; Hu Z; Liu X; Chen L; Ren X; Yao L; Sheng H; Li L; Ann D; Yen Y; Wang J; Wang X
Cancer Lett; 2016 Jul; 376(2):284-92. PubMed ID: 27063096
[TBL] [Abstract][Full Text] [Related]
31. An increased high-mobility group A2 expression level is associated with malignant phenotype in pancreatic exocrine tissue.
Abe N; Watanabe T; Suzuki Y; Matsumoto N; Masaki T; Mori T; Sugiyama M; Chiappetta G; Fusco A; Atomi Y
Br J Cancer; 2003 Dec; 89(11):2104-9. PubMed ID: 14647145
[TBL] [Abstract][Full Text] [Related]
32. Metformin alleviates breast cancer through targeting high-mobility group AT-hook 2.
Li Y; Wang D; Ren H; Feng W
Thorac Cancer; 2020 Mar; 11(3):686-692. PubMed ID: 32031335
[TBL] [Abstract][Full Text] [Related]
33. Targeting anillin inhibits tumorigenesis and tumor growth in hepatocellular carcinoma via impairing cytokinesis fidelity.
Chen J; Li Z; Jia X; Song W; Wu H; Zhu H; Xuan Z; Du Y; Zhu X; Song G; Dong H; Bian S; Wang S; Zhao Y; Xie H; Zheng S; Song P
Oncogene; 2022 May; 41(22):3118-3130. PubMed ID: 35477750
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional activation of FN1 and IL11 by HMGA2 promotes the malignant behavior of colorectal cancer.
Wu J; Wang Y; Xu X; Cao H; Sahengbieke S; Sheng H; Huang Q; Lai M
Carcinogenesis; 2016 May; 37(5):511-21. PubMed ID: 26964871
[TBL] [Abstract][Full Text] [Related]
35. HMGA2 regulates lung cancer proliferation and metastasis.
Gao X; Dai M; Li Q; Wang Z; Lu Y; Song Z
Thorac Cancer; 2017 Sep; 8(5):501-510. PubMed ID: 28752530
[TBL] [Abstract][Full Text] [Related]
36. Silencing of HMGA2 suppresses cellular proliferation, migration, invasion, and epithelial-mesenchymal transition in bladder cancer.
Shi Z; Li X; Wu D; Tang R; Chen R; Xue S; Sun X
Tumour Biol; 2016 Jun; 37(6):7515-23. PubMed ID: 26684800
[TBL] [Abstract][Full Text] [Related]
37. HMGA2 facilitates epithelial-mesenchymal transition in renal cell carcinoma by regulating the TGF-β/Smad2 signaling pathway.
Kou B; Liu W; Tang X; Kou Q
Oncol Rep; 2018 Jan; 39(1):101-108. PubMed ID: 29138866
[TBL] [Abstract][Full Text] [Related]
38. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
Haselmann V; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Fritsch J; Häsler R; Pickl A; Fritsche H; Annewanter F; Engler C; Fleig B; Bernt A; Röder C; Schmidt H; Gelhaus C; Hauser C; Egberts JH; Heneweer C; Rohde AM; Böger C; Knippschild U; Röcken C; Adam D; Walczak H; Schütze S; Janssen O; Wulczyn FG; Wajant H; Kalthoff H; Trauzold A
Gastroenterology; 2014 Jan; 146(1):278-90. PubMed ID: 24120475
[TBL] [Abstract][Full Text] [Related]
39. Metformin, a first-line drug for type 2 diabetes mellitus, disrupts the MALAT1/miR-142-3p sponge to decrease invasion and migration in cervical cancer cells.
Xia C; Liang S; He Z; Zhu X; Chen R; Chen J
Eur J Pharmacol; 2018 Jul; 830():59-67. PubMed ID: 29704494
[TBL] [Abstract][Full Text] [Related]
40. The regulation of acetylation and stability of HMGA2 via the HBXIP-activated Akt-PCAF pathway in promotion of esophageal squamous cell carcinoma growth.
Wu Y; Wang X; Xu F; Zhang L; Wang T; Fu X; Jin T; Zhang W; Ye L
Nucleic Acids Res; 2020 May; 48(9):4858-4876. PubMed ID: 32313942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]